Krentz, A J

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes

Krentz, A. J. (2003) · Diabetes Obesity and Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Cited by 205

Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans.

Boyle, P. J., Scott, J. C., Krentz, A. J., Nagy, R. J., Comstock, E., & Hoffman, C. (1994) · Journal of Clinical Investigation

Sleep and Wakefulness ResearchDiabetes Management and Research

Cited by 202

Machine learning based prediction models for cardiovascular disease risk using electronic health records data: systematic review and meta-analysis

Liu, T., Krentz, A., Lu, L., & Curcin, V. (2025) · European Heart Journal - Digital Health

Machine Learning in HealthcareArtificial Intelligence in Healthcare

Cited by 177

Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.

Boyle, P. J., Justice, K., Krentz, A. J., Nagy, R. J., & Schade, D. S. (1993) · The Journal of Clinical Endocrinology & Metabolism

Poisoning and overdose treatmentsDiabetes Treatment and Management

Cited by 125

The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)

Barnett, A. H., Krentz, A. J., Strojek, K., Sieradzki, J., Azizi, F., Embong, M., Imamoglu, S., Perušičová, J., Uličiansky, V., & Winkler, G. (2008) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 106